CoChat

The transplacental transfer efficiency of per- and polyfluoroalkyl substances (PFAS): a first meta-analysis

Open access

The DOI matches its Crossref record; 81 of the 84 references it cites were found in a registry or an index; 4 of the 48 sources its claims cite were checked for support.

Abstract

Per- and polyfluorinated substances (PFAS), ubiquitously present in the environment and biota, are transferred to the fetus via the placenta. PFAS can be distinguished, among other things, by their different carbon chain lengths and functional groups. The aim of this study was to provide comprehensive evidence on PFAS transfer rates across the human placental barrier by means of a meta-analysis based upon a systematic review. The available literature up to April 2021 was reviewed and transplacental transfer efficiencies (TTEs) of PFAS assessed. A total of 39 studies reporting data on 20 PFAS were included in the systematic review. Of these, 20 studies with data on 19 compounds were included in the meta-analysis. Comprehensive Meta-Analysis (CMA v3.0) was used for quantitative, statistical analyses with random effects models. A curvilinear relationship was found with short and long chains of perfluorocarboxylic acids (PFCAs) exhibiting higher TTE than compounds with intermediate chain length. Among the less well studied PFAS, perfluorohexanoic acid (PFHxA), 6:2 fluorotelomersulfonic acid (6:2 FTS) and perfluorobutanoic acid (PFBA) stood out the most with a high TEEs. The dependence of TTEs on chain length and functional group is clearly shown in this first meta-analysis on PFAS transfer across the human placenta. More data on effects of less well studied PFAS in pregnant women and neonates are needed to assess the potential risk for fetal exposure.

Overview

CoChat Summary

TL;DR

This first meta-analysis of PFAS transplacental transfer found that transfer efficiency depends on carbon chain length and functional group, with perfluorocarboxylic acids showing a U-shaped trend and carboxyl groups transferring more efficiently than sulfonyl groups. Less-studied PFAS such as PFHxA, 6:2 FTS, and PFBA showed high transfer efficiencies.

Key findings

  • The systematic review included 39 studies reporting data on 20 PFAS; the meta-analysis included 20 studies with data on 19 compounds. PFOS and PFOA were the most frequently measured, found in 37 studies with 3,937 maternal and 3,793 cord serum samples.
  • For PFCAs, random-effects TTEs showed a curvilinear/U-shaped relationship: PFHxA (C6) 2.19 ± 0.94, PFDA (C10) 0.32 ± 0.02, and PFTeDA (C14) 1.68 ± 0.17. PFBA (C4) had high variability and lower transfer than PFHxA.
  • For PFSAs, TTEs decreased with chain length: PFHxS (C6) 0.59 ± 0.03, PFHpS (C7) 0.58 ± 0.12, and PFOS (C8) 0.44 ± 0.02. PFOA TTE was approximately 2-fold higher than PFOS (0.8 vs. 0.44), indicating functional group effects.
  • Among “other PFAS,” 6:2 FTS had a TTE of 2.03 ± 0.51, PFOSA 0.84 ± 0.20, 6:2 Cl-PFESA 0.48 ± 0.03, 8:2 Cl-PFESA 0.71 ± 0.06, NMeFOSAA 0.94 ± 0.07, and NEtFOSAA 1.17 ± 0.10; no clear chain-length or functional-group trend was identified. Sampling time significantly affected PFOSA TTE (0.6 within two weeks of delivery vs. 1.27 at delivery), while year and region showed no marked effects.

Methods

  • Systematic review followed PRISMA and PECO, registered in PROSPERO (CRD42020210003); Scopus and PubMed were searched up to April 2021. From 496 records plus 8 hand-searched records, 355 remained after duplicate removal, 43 full texts were screened, and 39 studies were included in the systematic review.
  • Inclusion criteria were cross-sectional human studies reporting TTEs or data to calculate them, written in English; non-human studies and pooled blood samples were excluded. TTEs were calculated as cord blood concentration divided by maternal blood concentration when not reported.
  • Meta-analysis used Comprehensive Meta-Analysis (CMA v3.0) with random effects models; mean values were the effect size, and medians/IQRs were converted using Luo et al. (2018). Q-statistics, I², prediction intervals, pairwise mixed-effects comparisons, and moderation analyses (sampling time, region, year) were performed; risk of bias was assessed with AXIS and rated low.

Limitations

  • The paper states that insufficient data on PFSAs with chain length >C8 prevented assessment of a curvilinear relationship; some compounds had few studies (PFBA, PFHxA, PFHpA: 3–4 studies; PFBS: 2 studies and excluded from meta-analysis), and high variability/high standard deviations were striking for C4–C7 and C12–C14 compounds.
  • The authors note that no developmental outcome studies were found for 6:2 FTS, and data on PFHxA and PFBA effects on fetal health are limited; year and region findings may be too early to generalize due to low study numbers, and future meta-analyses should address structural specificities and analytical methods.
  • Evident from the text: only 20 of 39 systematic-review studies could be meta-analyzed due to missing descriptive statistics; outliers (e.g., Midasch et al. N=11; Li et al. high PFNA/PFTrDA; Cai et al. high TTEs with high SD) may influence estimates; detection limits and sampling timing may affect TTEs; no studies from South America or Australia met inclusion criteria.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1080/10937404.2021.2009946

Cites

81 of 84 references verified3 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

4 Valid · 2 Not valid · 30 Not checked · 62 Own results and interpretations

54 more claims

Create a free account to see all 98 claims and to verify the 6 references still open.

See all claims — free account
  • Probably not a substantial claim. 24
  • It may state two separate claims as one. 19
  • The quote only partly states this claim. 1

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 84 references

Research works printed but not linked: 2

  1. ATSDR. Agency for Toxic Substances and Disease Registry, 2021, Toxicological profile for perfluoroalkyls, chapter 2. Health effects
  2. Schrenk D., 2020, EFSA J., 18, e06223

Cited by

See all 107

Metadata

Authors
Appel, M., Forsthuber, M., Ramos, R., Widhalm, R., Granitzer, S., Uhl, M., Hengstschläger, M., Stamm, T., & Gundacker, C.
Affiliations
  • Medical University of Vienna (AT)
  • Karl Landsteiner University of Health Sciences (AT)
  • Environment Agency Austria (AT)
Corresponding author
Forsthuber, Martin
Venue
Journal of Toxicology and Environmental Health, Part B
Published
2021-12-20
Volume
25
Issue
1
Pages
23-42
ISSN
  • 1093-7404 (ISSN-L)
  • 1521-6950
OpenAlex
W4200163091
Cited by
104
References
81
Citations by year
2026: 28 · 2025: 29 · 2024: 21 · 2023: 20 · 2022: 6
FWCI
0.87
Type
journal article
Language
en
Open access
Locations
  • Journal of Toxicology and Environmental Health Part B (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
Funders
did not receive any specific grant
Topics
  • Physical Sciences › Environmental Science › Environmental Chemistry › Per- and polyfluoroalkyl substances research
  • Physical Sciences › Environmental Science › Health, Toxicology and Mutagenesis › Toxic Organic Pollutants Impact
  • Physical Sciences › Chemistry › Organic Chemistry › Fluorine in Organic Chemistry
Keywords
per- and polyfluoroalkyl substances, PFAS, placental barrier, perfluorocarboxylic acids, chain length, functional groups, perfluorohexanoic acid, perfluorobutanoic acid, prenatal exposure, pregnancy
MeSH terms
Caproates, Environmental Exposure, Environmental Pollutants, Female, Fluorocarbons, Humans, Infant, Newborn, Placenta, Pregnancy, Prenatal Exposure Delayed Effects

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-11-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-11-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The transplacental transfer efficiency of per- and polyfluoroalkyl substances (PFAS): a first meta-analysis. https://app.cochat.ai/papers/10.1080/10937404.2021.2009946
The paper
Appel, M., Forsthuber, M., Ramos, R., Widhalm, R., Granitzer, S., Uhl, M., Hengstschläger, M., Stamm, T., & Gundacker, C. (2022). The transplacental transfer efficiency of per- and polyfluoroalkyl substances (PFAS): a first meta-analysis. Journal of Toxicology and Environmental Health, Part B. https://doi.org/10.1080/10937404.2021.2009946

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.